Publications
Found 1 results
Filters: Author is H.Z.Y. Ozturk [Clear All Filters]
“Investigation of ABCB1 gene polymorphism with colchicine response in Behçet’s disease”, vol. 10, pp. 1-6, 2011.
,
Babaoglu MO, Bayar B, Aynacioglu AS, Kerb R, et al. (2005). Association of the ABCB1 3435C>T polymorphism with antiemetic efficacy of 5-hydroxytryptamine type 3 antagonists. Clin. Pharmacol. Ther. 78: 619-626.
http://dx.doi.org/10.1016/j.clpt.2005.08.015
PMid:16338277
Behçet H (1937). Uber rezidivierende aphthöse, durch ein Virus verursachte Geschwure, am Mund, am Auge, und an den Genitalien. Dermatol. Wschr. 105: 1152-1157.
Ben-Chetrit E and Levy M (1998). Does the lack of the P-glycoprotein efflux pump in neutrophils explain the efficacy of colchicine in familial Mediterranean fever and other inflammatory diseases? Med. Hypotheses 51: 377-380.
http://dx.doi.org/10.1016/S0306-9877(98)90031-7
Ehrenfeld M, Levy M, Bar EM, Gallily R, et al. (1980). Effect of colchicine on polymorphonuclear leucocyte chemotaxis in human volunteers. Br. J. Clin. Pharmacol. 10: 297-300.
http://dx.doi.org/10.1111/j.1365-2125.1980.tb01759.x
PMid:7437248 PMCid:1430072
Ertel NH and Wallace SL (1971). Measurement of colchicine in urine and peripheral leucocytes. Clin. Res. 19: 348.
Gershoni-Baruch R, Peretz Y, Merav L, Dagan E, et al. (2005). The Influence of Polymorphisms in MDR1 on Colchicine Unresponsiveness in Familial Mediterranean Fever. In: The Fourth International Congress on Systemic Autoinflammatory Diseases, November 6-10, Bethesda, 25.
Hoffmeyer S, Burk O, von Richter O, Arnold HP, et al. (2000). Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl. Acad. Sci. U. S. A. 97: 3473-3478.
http://dx.doi.org/10.1073/pnas.97.7.3473
PMid:10716719 PMCid:16264
Illmer T, Schuler US, Thiede C, Schwarz UI, et al. (2002). MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. Cancer Res. 62: 4955-4962.
PMid:12208746
International Study Group for Behçet's Disease Contributors (1991). Evaluation of Diagnostic ("Classification") Criteria in Behçet's Disease: Toward Internationally Agreed Criteria. In: Behçet's Disease: Basic and Clinical Aspects (O' Duffy and Kökmen B, eds.). Marcel Dekker, New York, 11-39.
Kim RB (2002). Drugs as P-glycoprotein substrates, inhibitors, and inducers. Drug Metab. Rev. 34: 47-54.
http://dx.doi.org/10.1081/DMR-120001389
PMid:11996011
Marzolini C, Paus E, Buclin T and Kim RB (2004). Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin. Pharmacol. Ther. 75: 13-33.
http://dx.doi.org/10.1016/j.clpt.2003.09.012
PMid:14749689
Miao LY, Huang CR, Hou JQ and Qian MY (2008). Association study of ABCB1 and CYP3A5 gene polymorphisms with sirolimus trough concentration and dose requirements in Chinese renal transplant recipients. Biopharm. Drug Dispos. 29: 1-5.
http://dx.doi.org/10.1002/bdd.577
PMid:17941052
Rund D, Azar I and Shperling O (1999). A mutation in the promoter of the multidrug resistance gene (MDR1) in human hematological malignancies may contribute to the pathogenesis of resistant disease. Adv. Exp. Med. Biol. 457: 71-75.
http://dx.doi.org/10.1007/978-1-4615-4811-9_9
PMid:10500782
Tufan A, Babaoglu MO, Akdogan A, Yasar U, et al. (2007). Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever. J. Rheumatol. 34: 1540-1544.
PMid:17610314
Yurdakul S, Mat C, Tuzun Y, Ozyazgan Y, et al. (2001). A double-blind trial of colchicine in Behcet's syndrome. Arthritis Rheum. 44: 2686-2692.
http://dx.doi.org/10.1002/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H
Zhou SF (2008). Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 38: 802-832.
http://dx.doi.org/10.1080/00498250701867889
PMid:18668431